264 related articles for article (PubMed ID: 23150340)
21. [Tumor suppressor gene p53].
Tokino T
Nihon Rinsho; 1996 Apr; 54(4):960-4. PubMed ID: 8920657
[TBL] [Abstract][Full Text] [Related]
22. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
23. [Toll-like receptors: recognition receptors of the innate immune system and target structures for therapeutical intervention].
Kabelitz D
Med Monatsschr Pharm; 2012 Jul; 35(7):238-44. PubMed ID: 22852274
[TBL] [Abstract][Full Text] [Related]
24. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
25. Direct and indirect role of Toll-like receptors in T cell mediated immunity.
Xu D; Liu H; Komai-Koma M
Cell Mol Immunol; 2004 Aug; 1(4):239-46. PubMed ID: 16225766
[TBL] [Abstract][Full Text] [Related]
26. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
Conroy H; Marshall NA; Mills KH
Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
[TBL] [Abstract][Full Text] [Related]
27. [Innate immunity: structure and function of TLRs].
Delneste Y; Beauvillain C; Jeannin P
Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
[TBL] [Abstract][Full Text] [Related]
28. TLR signaling by tumor and immune cells: a double-edged sword.
Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
[TBL] [Abstract][Full Text] [Related]
29. Regulatory T cells and Toll-like receptors in tumor immunity.
Wang RF; Peng G; Wang HY
Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
[TBL] [Abstract][Full Text] [Related]
30. Induction of genetic instability by gain-of-function p53 cancer mutants.
Xu Y
Oncogene; 2008 Jun; 27(25):3501-7. PubMed ID: 18223686
[TBL] [Abstract][Full Text] [Related]
31. Fish cell cultures as in vitro models of inflammatory responses elicited by immunostimulants. Expression of regulatory genes of the innate immune response.
Fierro-Castro C; Barrioluengo L; López-Fierro P; Razquin BE; Villena AJ
Fish Shellfish Immunol; 2013 Sep; 35(3):979-87. PubMed ID: 23872473
[TBL] [Abstract][Full Text] [Related]
32. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
33. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
Mendoza-Rodríguez CA; Cerbón MA
Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
[TBL] [Abstract][Full Text] [Related]
34. Regulation of innate immune responses by Toll-like receptors.
Takeda K; Akira S
Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
[TBL] [Abstract][Full Text] [Related]
35. Protein tyrosine phosphatase with proline-glutamine-serine-threonine-rich motifs negatively regulates TLR-triggered innate responses by selectively inhibiting IκB kinase β/NF-κB activation.
Zhang P; Liu X; Li Y; Zhu X; Zhan Z; Meng J; Li N; Cao X
J Immunol; 2013 Feb; 190(4):1685-94. PubMed ID: 23296707
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity.
Doyle SL; O'Neill LA
Biochem Pharmacol; 2006 Oct; 72(9):1102-13. PubMed ID: 16930560
[TBL] [Abstract][Full Text] [Related]
37. The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents.
Makkouk A; Abdelnoor AM
Immunopharmacol Immunotoxicol; 2009; 31(3):331-8. PubMed ID: 19555209
[TBL] [Abstract][Full Text] [Related]
38. Regulation of p53 by ING family members in suppression of tumor initiation and progression.
Jafarnejad SM; Li G
Cancer Metastasis Rev; 2012 Jun; 31(1-2):55-73. PubMed ID: 22095030
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptors in human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
[TBL] [Abstract][Full Text] [Related]
40. Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state.
Broering R; Montag M; Jiang M; Lu M; Sowa JP; Kleinehr K; Gerken G; Schlaak JF
Int Immunol; 2011 Sep; 23(9):537-44. PubMed ID: 21750146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
